1. Rush, A, Christiansen, JH, Farrell, JP, et al. Biobank classification in an Australian setting. Biopreserv Biobank. 2015;13:212-218.
Google Scholar | Crossref | Medline | ISI2. Rush, A, Catchpoole, DR, Ling, R, Searles, A, Watson, PH, Byrne, JA. Improving academic biobank value and sustainability through an outputs focus. Value Health. 2020;23:1072-1078.
Google Scholar | Crossref | Medline3. Pepe, MS, Etzioni, R, Feng, Z, et al. Phases of biomarker development for early detection of cancer. J Natl Cancer Inst. 2001;93:1054-1061.
Google Scholar | Crossref | Medline4. Allocca, CM, Bledsoe, MJ, Albert, M, et al. Biobanking in the COVID-19 era and beyond: Part 1. How early experiences can translate into actionable wisdom. Biopreserv Biobank. 2020;18:533-546.
Google Scholar | Crossref | Medline5. Arturo, EC, Saphire, EO. Lifted Up from Lockdown. Cell. 2020;183:1-3.
Google Scholar | Crossref | Medline6. Omary, MB, Eswaraka, J, Kimball, SD, Moghe, PV, Panettieri, RA, Scotto, KW. The COVID-19 pandemic and research shutdown: staying safe and productive. J Clin Invest. 2020;130:2745-2748.
Google Scholar | Crossref | Medline7. Goh, HH, Bourne, PE. Ten simple rules for researchers while in isolation from a pandemic. PLoS Comput Biol. 2020;16:e1007946.
Google Scholar | Crossref8. Saini, KS, de Las Heras, B, de Castro, J, et al. Effect of the COVID-19 pandemic on cancer treatment and research. Lancet Haematol. 2020;7:e432-e435.
Google Scholar | Crossref | Medline9. Tuttle, KR. Impact of the COVID-19 pandemic on clinical research. Nat Rev Nephrol. 2020;16:562-564.
Google Scholar | Crossref | Medline10. Zon, L, Gomes, AP, Cance, WG, et al. Impact of COVID-19 pandemic on cancer research. Cancer Cell. 2020;38:591-593.
Google Scholar | Crossref | Medline11. Kalia, V, Srinivasan, A, Wilkins, L, Luker, GD. Adapting scientific conferences to the realities imposed by COVID-19. Radiol Imag Cancer. 2020;2:4.
Google Scholar12. Simeon-Dubach, D, Henderson, MK. Opportunities and risks for research biobanks in the COVID-19 era and beyond. Biopreserv Biobank. 2020;18:503-510.
Google Scholar | Crossref | Medline13. Watson, PH, Barnes, RO. A proposed schema for classifying human research biobanks. Biopreserv Biobank. 2011;9:327-333.
Google Scholar | Crossref | Medline14. Barnes, RO, Schacter, B, Kodeeswaran, S, Watson, PH; CTRNet Management Committee . Funding sources for Canadian biorepositories: the role of user fees and strategies to help fill the gap. Biopreserv Biobank. 2014;12:300-305.
Google Scholar | Crossref | Medline15. Rush, A, Matzke, L, Cooper, S, et al. Research perspective on utilizing and valuing tumour biobanks. Biopreserv Biobank. 2018;17:219-229.
Google Scholar | Crossref | Medline16. Baber, R, Kiehntopf, M. Automation in biobanking from a laboratory medicine perspective. J Lab Med. 2019;43:329-338.
Google Scholar | Crossref17. Aarden, E. Projecting and producing ‘usefulness’ of biomedical research infrastructures; or why the Singapore Tissue Network closed. Sci Public Policy. 2017;44:753-762.
Google Scholar | Crossref18. Wei, CT. The closure of the national bio-bank in Singapore. Asia Pac Biotech News. 2012;16:41-43.
Google Scholar19. Andry, C, Duffy, E, Moskaluk, CA, McCall, S, Roehrl, MHA, Remick, D. Biobanking-budgets and the role of pathology biobanks in precision medicine. Acad Pathol. 2017;4:2374289517702924.
Google Scholar | SAGE Journals20. Doucet, M, Yuille, M, Georghiou, L, Dagher, G. Biobank sustainability: current status and future prospects. J Biorepos Sci App Med. 2017;5:1-7.
Google Scholar | Crossref21. Grizzle, WE, Bledsoe, MJ, Al Diffalha, S, Otali, D, Sexton, KC. The utilization of biospecimens: impact of the choice of biobanking model. Biopreserv Biobank. 2019;17:230-242.
Google Scholar | Crossref | Medline22. Fortin, S, Pathmasiri, S, Grintuch, R, Deschênes, M. ‘Access arrangements’ for biobanks: a fine line between facilitating and hindering collaboration. Public Health Genomics. 2011;14:104-114.
Google Scholar | Crossref | Medline | ISI23. Cadigan, RJ, Juengst, E, Davis, A, Henderson, G. Underutilization of specimens in biobanks: an ethical as well as a practical concern? Genet Med. 2014;16:738-740.
Google Scholar | Crossref | Medline24. Chalmers, D, Nicol, D, Kaye, J, et al. Has the biobank bubble burst? Withstanding the challenges for sustainable biobanking in the digital era. BMC Med Ethics. 2016;17:39.
Google Scholar | Crossref | Medline25. Matzke, LA, Fombonne, B, Watson, PH, Moore, HM. Fundamental considerations for biobank legacy planning. Biopreserv Biobank. 2016;14:99-106.
Google Scholar | Crossref | Medline26. Tupasela, A, Stephens, N. The boom and bust cycle of biobanking – thinking through the life cycle of biobanks. Croat Med J. 2013;54:501-503.
Google Scholar | Crossref | Medline27. Myers, KR, Tham, WY, Yin, Y, et al. Unequal effects of the COVID-19 pandemic on scientists. Nat Hum Behav. 2020;4:880-883.
Google Scholar | Crossref | Medline28. Moore, HM, Kelly, AB, Jewell, SD, et al. Biospecimen reporting for improved study quality (BRISQ). J Proteome Res. 2011;10:3429-3438.
Google Scholar | Crossref | Medline | ISI29. Simeon-Dubach, D, Watson, P. Biobanking 3.0: evidence based and customer focused biobanking. Clin Biochem. 2014;47:300-308.
Google Scholar | Crossref | Medline30. Lawrence, E, Sims, J, Gander, A, et al. The barriers and motivators to using human tissues for research: the views of UK-based biomedical researchers. Biopreserv Biobank. 2020;18:266-273.
Google Scholar | Crossref | Medline31. Zierath, JR. Building bridges through scientific conferences. Cell. 2016;167:1155-1158.
Google Scholar32. Andereggen, S, Zoller, FA, Boutellier, R. Sharing research equipment to bridge intraorganizational boundaries. Res-Tech Management. 2013;56:49-57.
Google Scholar | Crossref33. Rush, A, Spring, K, Byrne, JA. A critical analysis of cancer biobank practices in relation to biospecimen quality. Biophys Rev. 2015;7:369-378.
Google Scholar | Crossref | Medline34. Ioannidis, JPA, Thombs, BD. A user’s guide to inflated and manipulated impact factors. Eur J Clin Invest. 2019;49:e13151.
Google Scholar | Crossref35. LaBaer, J. Improving international research with clinical specimens: 5 achievable objectives. J Proteome Res. 2012;11:5592-5601.
Google Scholar | Crossref | Medline36. Ortega-Paíno, E, Tupasela, A. Biobanks and biobank networks. In: Minssen, T, Janne, R, Herrmann, JR, Schovsbo, J, eds. Global Genes, Local Concerns: Legal, Ethical, and Scientific Challenges in International Biobanking. Edward Elgar Publishing Limited; 2019:229-241.
Google Scholar37. Shickle, D, Griffin, M, El-Arifi, K. Inter- and intra-biobank networks: classification of biobanks. Pathobiol. 2010;77:181-190.
Google Scholar | Crossref | Medline | ISI38. Light, E, Wiersma, M, Dive, L, et al. Biobank networking and globalisation: perspectives and practices of Australian biobanks. Aust Health Rev. 2021;45:214-222.
Google Scholar | Crossref | Medline39. George, G, Wang, XM, Linton, J, et al. Toward a synergistic operating model for westmead research hub biobanks: a questionnaire study. Biopreserv Biobank. 2019;17:570-576.
Google Scholar | Crossref | Medline40. Byrne, J ; ANZCHOG Biobanking Network . The Australian and New Zealand children’s haematology/oncology group biobanking network. Biopreserv Biobank. 2019;17:95-97.
Google Scholar | Crossref | Medline41. Peeling, RW, Boeras, D, Wilder-Smith, A, Sall, A, Nkengasong, J. Need for sustainable biobanking networks for COVID-19 and other diseases of epidemic potential. Lancet Infect Dis. 2020;20:e268-e273.
Google Scholar | Crossref42. Simeon-Dubach, D, Roehrl, MH, Hofman, P, Puchois, P. Enhancing cooperation between academic biobanks and biomedical industry: better mutual understanding and new collaborative models are needed. Biopreserv Biobank. 2020;18:144-149.
Google Scholar | Crossref | Medline43. Carvalho, K, Gali, B, LeBlanc, J, Matzke, LA, Watson, PH. A permission to contact platform is an efficient and cost-effective enrollment method for a biobank to create study-specific research cohorts. Biopreserv Biobank. Posted online January 18, 2021. doi:10.1089/bio.2020.0114
Google Scholar | Crossref44. Stephens, N, Dimond, R. Closure of a human tissue biobank: individual, institutional, and field expectations during cycles of promise and disappointment. New Genet Soc. 2015;34:417-436.
Google Scholar | Crossref45. Larsson, A, Savage, C, Brommels, M, Mattsson, P. Structuring a research infrastructure: a study of the rise and fall of a large-scale distributed biobank facility. Soc Sci Inf. 2018;57:196-222.
Google Scholar | SAGE Journals | ISI46. Castellanos-Uribe, M, Gormally, E, Zhou, H, Matzke, E, Watson, PH. Biobanking education. Biopreserv Biobank. 2020;18:1-3.
Google Scholar | Crossref | Medline47. Kinkorová, J. Education for future biobankers – The state-of-the-art and outlook. EPMA J. 2021;12:1-11.
Google Scholar | Crossref48. Kleiderman, E, Pack, A, Borry, P, Zawati, M. The author who wasn’t there? Fairness and attribution in publications following access to population biobanks. PLoS One. 2018;13:e0194997.
Google Scholar | Crossref | Medline49. Mason, JL, Johnston, E, Berndt, S, Segal, K, Lei, M, Wiest, JS. Labor and skills gap analysis of the biomedical research workforce. FASEB J. 2016;30:2673-2683.
Google Scholar | Crossref | Medline50. Rzhetsky, A, Foster, JG, Foster, IT, Evans, JA. Choosing experiments to accelerate collective discovery. Proc Natl Acad Sci U S A. 2015;112:14569-14574.
Google Scholar | Crossref | Medline | ISI